Abstract
The rise of multidrug-resistant human pathogenic bacteria is calling for alternative approaches to design antibacterial drugs. Here, we review new approaches based on antisense oligonucleotides as antibacterial agents, fecal microbiota transplantation, and antimicrobial peptides and cell-penetrating peptides with antibacterial activity.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
